Windlas Biotech Profile
Key Indicators
- Authorised Capital ₹ 77.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 10.45 Cr
as on 24-10-2024
- Company Age 23 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 58.90 Cr
as on 24-10-2024
- Satisfied Charges ₹ 182.90 Cr
as on 24-10-2024
- Revenue 10.67%
(FY 2023)
- Profit 10.59%
(FY 2023)
- Ebitda 13.89%
(FY 2023)
- Net Worth 1.91%
(FY 2023)
- Total Assets 7.74%
(FY 2023)
About Windlas Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543329 and on the National Stock Exchange(NSE) under WINDLAS.
The Corporate was formerly known as Windlas Biotech Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 77.50 Cr and a paid-up capital of Rs 10.45 Cr.
The company currently has active open charges totaling ₹58.90 Cr. The company has closed loans amounting to ₹182.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Windlas Biotech Limited India are Ananta Panda as COMPANY SECRETARY and Komal Gupta as Ceo. Ashok Windlass, Manoj Windlass, Srinivasan Venkataraman, and Five other members serve as directors at the Company.
Industry
Company Details
- LocationDehradun, Uttarakhand
- Telephone
- Email Address
- Website
- Social Media
What products or services does Windlas Biotech Limited offer?
Windlas Biotech Limited offers a wide range of products and services, including Insulin Injection, Ozempic Semaglutide Injection.
Who are the key members and board of directors at Windlas Biotech?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Windlass  | Managing Director | 21-Jan-2008 | Current |
Manoj Windlass  | Managing Director | 01-Apr-2006 | Current |
| Ananta Panda | Company Secretary | 02-Apr-2021 | Current |
| Komal Gupta | CEO | 12-May-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prachi Windlass | Director | 03-May-2021 | Current |
| Ashok Windlass | Whole-Time Director | 19-Feb-2001 | Current |
| Srinivasan Venkataraman | Director | 06-May-2021 | Current |
| Gaurav Gulati | Director | 06-May-2021 | Current |
| Vivek Dhariwal | Director | 06-May-2021 | Current |
| Pawan Sharma | Whole-Time Director | 11-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Windlas Biotech.
Windlas Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.67% increase. The company also saw a substantial improvement in profitability, with a 10.59% increase in profit. The company's net worth moved up by a moderate rise of 1.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Windlas Biotech?
In 2023, Windlas Biotech had a promoter holding of 62.37% and a public holding of 37.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Practus Business Transformation Private LimitedActive 5 years 3 monthsSrinivasan Venkataraman is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 27 May 2022 | ₹25.10 Cr | Open |
Sidbi Creation Date: 13 Jul 2020 | ₹5.00 M | Open |
Others Creation Date: 04 Feb 2015 | ₹10.00 Cr | Open |
How Many Employees Work at Windlas Biotech?
Windlas Biotech has a workforce of 939 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Windlas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Windlas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
